• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects.

作者信息

Arvidsson A, Alván G, Strandvik B

出版信息

Acta Paediatr Scand. 1983 Mar;72(2):293-4. doi: 10.1111/j.1651-2227.1983.tb09715.x.

DOI:10.1111/j.1651-2227.1983.tb09715.x
PMID:6837304
Abstract
摘要

相似文献

1
Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects.囊性纤维化患者与正常受试者之间头孢磺啶肾脏处理的差异。
Acta Paediatr Scand. 1983 Mar;72(2):293-4. doi: 10.1111/j.1651-2227.1983.tb09715.x.
2
Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.由于囊性纤维化患者肾小球滤过率较高，头孢磺啶的肾脏清除率增加。
Clin Pharmacokinet. 1990 Feb;18(2):168-75. doi: 10.2165/00003088-199018020-00006.
3
Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.头孢磺啶在囊性纤维化患者中的单剂量药代动力学。
Antimicrob Agents Chemother. 1984 May;25(5):579-81. doi: 10.1128/AAC.25.5.579.
4
Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.头孢甲肟与其他头孢菌素的肾脏排泄机制比较：对氨基马尿酸对家兔头孢菌素肾清除率及肾内分布的影响
J Antibiot (Tokyo). 1981 Nov;34(11):1476-85. doi: 10.7164/antibiotics.34.1476.
5
Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.肾小球滤过率对囊性纤维化患者头孢他啶肾清除率的影响。
Clin Pharmacokinet. 1988 Jul;15(1):57-65. doi: 10.2165/00003088-198815010-00005.
6
Cefsulodin kinetics in renal impairment.头孢磺啶在肾功能损害中的动力学
Clin Pharmacol Ther. 1982 May;31(5):602-8. doi: 10.1038/clpt.1982.84.
7
Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
Clin Pharmacol Ther. 1993 Sep;54(3):293-302. doi: 10.1038/clpt.1993.150.
8
Cephalosporin therapeutics in cystic fibrosis.囊性纤维化中的头孢菌素疗法。
J Pediatr. 1986 May;108(5 Pt 2):854-60. doi: 10.1016/s0022-3476(86)80757-0.
9
Decreased renal clearance of sodium in cystic fibrosis.囊性纤维化患者钠的肾脏清除率降低。
Acta Paediatr Scand. 1991 Feb;80(2):194-8. doi: 10.1111/j.1651-2227.1991.tb11833.x.
10
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:297-311. doi: 10.1093/jac/12.suppl_a.297.

引用本文的文献

1
Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data.囊性纤维化患者静脉内药物处置的改变：自上而下和自下而上数据整合的荟萃分析。
CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):951-966. doi: 10.1002/psp4.12832. Epub 2022 Jun 29.
2
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.四十年来囊性纤维化患者β-内酰胺类抗生素的药代动力学研究
Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x.
3
Renal function in pediatric cystic fibrosis patients in the first decade of life.
儿童囊性纤维化患者生命最初十年的肾功能。
Pediatr Nephrol. 2011 Apr;26(4):605-12. doi: 10.1007/s00467-010-1737-1. Epub 2010 Dec 29.
4
Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers.囊性纤维化患者和健康志愿者中头孢他啶的群体药代动力学比较和药效学折点。
Antimicrob Agents Chemother. 2010 Mar;54(3):1275-82. doi: 10.1128/AAC.00936-09. Epub 2010 Jan 11.
5
Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport?囊性纤维化患者对抗生素的肾脏清除率增强能否用P-糖蛋白转运来解释？
Pharm Res. 2002 Apr;19(4):457-62. doi: 10.1023/a:1015191511817.
6
Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.囊性纤维化患者抗菌治疗的药代动力学优化。当前实践及未来方向建议。
Clin Pharmacokinet. 1998 Dec;35(6):437-59. doi: 10.2165/00003088-199835060-00003.
7
Drug disposition in cystic fibrosis.囊性纤维化中的药物处置
Clin Pharmacokinet. 1998 Oct;35(4):313-29. doi: 10.2165/00003088-199835040-00004.
8
Pharmacokinetics of cefepime in cystic fibrosis patients.头孢吡肟在囊性纤维化患者中的药代动力学。
Antimicrob Agents Chemother. 1993 Jul;37(7):1414-6. doi: 10.1128/AAC.37.7.1414.
9
Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.头孢磺啶在囊性纤维化患者中的单剂量药代动力学。
Antimicrob Agents Chemother. 1984 May;25(5):579-81. doi: 10.1128/AAC.25.5.579.
10
Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test.囊性纤维化中对氨基苯甲酸（PABA）药代动力学的改变。对苯替酪胺试验的影响。
Dig Dis Sci. 1985 Oct;30(10):928-32. doi: 10.1007/BF01308291.